BSD Medical to begin Phase III pancreatic cancer study
BSD Medical, a manufacturer of services systems to treat cancer using heat therapy, will start Phase III pancreatic cancer study.
The randomized, multicenter study will use the BSD-2000 Hyperthermia System to deliver hyperthermia.
The study will compare hyperthermia with chemotherapy (gemcitabine plus cisplatin) to chemotherapy (gemcitabine) alone.
BSD said patients will be randomized following standard surgical resection of the tumor, and the enrollment is scheduled from 1 April 2012.
Related Insight
Suppliers Directory
Specialty Devices
Anesthesia & Respiratory Devices
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Drug Delivery Devices
Orthopedic Devices
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Surgical & Supplies Intelligence
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.